4//SEC Filing
Pawlicki Raymond 4
Accession 0001127602-13-007946
CIK 0000875045other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 1:24 PM ET
Size
8.7 KB
Accession
0001127602-13-007946
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
Pawlicki Raymond
SVP, Chief Information Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2013-02-23−1,529→ 1,527 totalExercise: $0.00Exp: 2014-02-23→ Common Stock (1,529 underlying) - Exercise/Conversion
Common Stock
2013-02-23+1,529→ 10,761.711 total - Tax Payment
Common Stock
2013-02-23$164.40/sh−722$118,697→ 10,039.711 total
Footnotes (1)
- [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
Documents
Issuer
BIOGEN IDEC INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001547904
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 1:24 PM ET
- Size
- 8.7 KB